BIOMAT Database Logo BIOMAT Database Logo

A comparative double-blind adjustable dose clinical trial of penbutolol and propranolol in angina pectoris. 1977

C V Bhirmanandan, and J S Chadha, and P L Sharma, and P L Wahi

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000787 Angina Pectoris The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION. Angor Pectoris,Stenocardia,Stenocardias

Related Publications

C V Bhirmanandan, and J S Chadha, and P L Sharma, and P L Wahi
Penbutolol and molsidomine synergism in angina pectoris. A double blind ergometric trial.
January 1984, European journal of clinical pharmacology,
C V Bhirmanandan, and J S Chadha, and P L Sharma, and P L Wahi
DOUBLE-BLIND TRIAL OF PROPRANOLOL (INDERAL) IN ANGINA PECTORIS.
April 1965, British medical journal,
C V Bhirmanandan, and J S Chadha, and P L Sharma, and P L Wahi
Double-blind crossover clinical trial of oxyfedrine and propranolol in angina pectoris.
April 1985, International journal of clinical pharmacology, therapy, and toxicology,
C V Bhirmanandan, and J S Chadha, and P L Sharma, and P L Wahi
Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
February 1984, Herz,
C V Bhirmanandan, and J S Chadha, and P L Sharma, and P L Wahi
Double blind trial of propranolol and pindolol in angina pectoris.
July 1975, JPMA. The Journal of the Pakistan Medical Association,
C V Bhirmanandan, and J S Chadha, and P L Sharma, and P L Wahi
Double blind cross-over clinical trial of acebutolol and propranolol in angina pectoris.
November 1985, International journal of clinical pharmacology, therapy, and toxicology,
C V Bhirmanandan, and J S Chadha, and P L Sharma, and P L Wahi
Variable dose comparative trial of propranolol and sotalol in angina pectoris.
May 1973, British heart journal,
C V Bhirmanandan, and J S Chadha, and P L Sharma, and P L Wahi
Double-blind comparison of prenylamine and penbutolol in patients with angina pectoris.
January 1985, The Journal of international medical research,
C V Bhirmanandan, and J S Chadha, and P L Sharma, and P L Wahi
A double-blind trial of penbutolol: a new beta-receptor blocking agent in the treatment of angina pectoris.
January 1976, The Journal of international medical research,
C V Bhirmanandan, and J S Chadha, and P L Sharma, and P L Wahi
Double-blind three-dose trial of oral alprenolol in angina pectoris.
July 1971, British heart journal,
Copied contents to your clipboard!